ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
Clinical trials for ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted pill holds promise for rare salivary gland cancer that spreads
Disease control Not yet recruitingThis phase 2 trial tests the drug zanzalintinib in people whose adenoid cystic carcinoma (a rare salivary gland cancer) has returned or spread. Despite initial surgery and radiation, about half of patients experience recurrence, and current treatments offer limited benefit. Parti…
Matched conditions: ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy takes aim at Hard-to-Treat salivary gland cancer
Disease control Not yet recruitingThis phase II trial tests a combination of an antibody-drug conjugate (a targeted cancer drug) and stereotactic body radiotherapy (precise, high-dose radiation) in 40 people with recurrent or metastatic salivary gland cancer. Participants first receive the drug; if their disease …
Matched conditions: ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC